138 related articles for article (PubMed ID: 2983168)
21. 5HT2 binding sites after mianserin: comparison of loss of sites and brain levels of drug.
Sanders-Bush E; Breeding M; Roznoski M
Eur J Pharmacol; 1987 Jan; 133(2):199-204. PubMed ID: 3816985
[TBL] [Abstract][Full Text] [Related]
22. Differential binding of 3H-imipramine and 3H-mianserin in rat cerebral cortex.
Dumbrille-Ross A; Tang SW; Coscina DV
Life Sci; 1981 Nov; 29(20):2049-58. PubMed ID: 7311732
[No Abstract] [Full Text] [Related]
23. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
Teitler M; Leonhardt S; Weisberg EL; Hoffman BJ
Mol Pharmacol; 1990 Nov; 38(5):594-8. PubMed ID: 2233696
[TBL] [Abstract][Full Text] [Related]
24. Daily bupropion injections for 3 weeks attenuate the NE stimulation of adenylate cyclase and the number of beta-adrenergic recognition sites in rat frontal cortex.
Gandolfi O; Barbaccia ML; Chuang DM; Costa E
Neuropharmacology; 1983 Jul; 22(7):927-9. PubMed ID: 6312356
[TBL] [Abstract][Full Text] [Related]
25. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
Nash JF; Arora RC; Schreiber MA; Meltzer HY
Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633
[TBL] [Abstract][Full Text] [Related]
26. Modulation of the serotonin S2-receptor in brain after chronic lithium.
Wajda IJ; Banay-Schwartz M; Manigault I; Lajtha A
Neurochem Res; 1986 Jul; 11(7):949-57. PubMed ID: 2944024
[TBL] [Abstract][Full Text] [Related]
27. [3H]ketanserin (serotonin type 2) binding increases in rat cortex following basal forebrain lesions with ibotenic acid.
Wenk GL; Engisch KL
J Neurochem; 1986 Sep; 47(3):845-50. PubMed ID: 2942641
[TBL] [Abstract][Full Text] [Related]
28. Serotonin-1C sites in the choroid plexus are not linked in a stimulatory or inhibitory way to adenylate cyclase.
Palacios JM; Markstein R; Pazos A
Brain Res; 1986 Aug; 380(1):151-4. PubMed ID: 3019464
[TBL] [Abstract][Full Text] [Related]
29. Adrenergic regulation of [3H]ketanserin binding sites during immobilization stress in the rat frontal cortex.
Torda T; Murgas K; Cechova E; Kiss A; Saavedra JM
Brain Res; 1990 Sep; 527(2):198-203. PubMed ID: 1701336
[TBL] [Abstract][Full Text] [Related]
30. 5-HT2 receptors, roles and regulation.
Leysen JE; Pauwels PJ
Ann N Y Acad Sci; 1990; 600():183-91; discussion 192-3. PubMed ID: 2252309
[TBL] [Abstract][Full Text] [Related]
31. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding.
Pranzatelli MR; Murthy JN; Pluchino RS
J Pharmacol Exp Ther; 1992 Apr; 261(1):161-5. PubMed ID: 1560361
[TBL] [Abstract][Full Text] [Related]
32. Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.
Sanders-Bush E; Breeding M
J Pharmacol Exp Ther; 1988 Oct; 247(1):169-73. PubMed ID: 3139864
[TBL] [Abstract][Full Text] [Related]
33. 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants.
Kendall DA; Nahorski SR
J Pharmacol Exp Ther; 1985 May; 233(2):473-9. PubMed ID: 2987487
[TBL] [Abstract][Full Text] [Related]
34. Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade in spontaneously hypertensive rats.
Cohen ML; Fuller RW; Kurz KD
Hypertension; 1983; 5(5):676-81. PubMed ID: 6311738
[TBL] [Abstract][Full Text] [Related]
35. Different synaptic location of mianserin and imipramine binding sites.
Brunello N; Chuang DM; Costa E
Science; 1982 Feb; 215(4536):1112-5. PubMed ID: 6278586
[TBL] [Abstract][Full Text] [Related]
36. [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.
Leysen JE; Niemegeers CJ; Van Nueten JM; Laduron PM
Mol Pharmacol; 1982 Mar; 21(2):301-14. PubMed ID: 7099138
[No Abstract] [Full Text] [Related]
37. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
Eison AS; Eison MS; Yocca FD; Gianutsos G
Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
[TBL] [Abstract][Full Text] [Related]
38. Hypotensive activity of serotonin antagonists; correlation with alpha 1-adrenoceptor and serotonin receptor blockade.
Kalkman HO; Harms YM; van Gelderen EM; Batink HD; Timmermans PB; van Zwieten PA
Life Sci; 1983 Mar; 32(13):1499-505. PubMed ID: 6300582
[TBL] [Abstract][Full Text] [Related]
39. Specific binding of [3H]mianserin and [3H]imipramine to structures of rat hippocampus.
Brunello N; Chuang DM; Costa E
Eur J Pharmacol; 1982 Mar; 78(3):383-4. PubMed ID: 7067734
[No Abstract] [Full Text] [Related]
40. Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT-2 binding site.
Conn PJ; Sanders-Bush E
J Neurosci; 1986 Dec; 6(12):3669-75. PubMed ID: 3025382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
